Daklak Pharmaceutical Medical Performance
Daklak Pharmaceutical Relative Risk vs. Return Landscape
If you would invest (100.00) in Daklak Pharmaceutical Medical on September 20, 2024 and sell it today you would earn a total of 100.00 from holding Daklak Pharmaceutical Medical or generate -100.0% return on investment over 90 days. Daklak Pharmaceutical Medical is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Daklak, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Daklak Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Daklak Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Daklak Pharmaceutical Medical, and traders can use it to determine the average amount a Daklak Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DBM |
Based on monthly moving average Daklak Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Daklak Pharmaceutical by adding Daklak Pharmaceutical to a well-diversified portfolio.
Things to note about Daklak Pharmaceutical performance evaluation
Checking the ongoing alerts about Daklak Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Daklak Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Daklak Pharmaceutical is not yet fully synchronised with the market data | |
| Daklak Pharmaceutical has some characteristics of a very speculative penny stock |
- Analyzing Daklak Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Daklak Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Daklak Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Daklak Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Daklak Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Daklak Pharmaceutical's stock. These opinions can provide insight into Daklak Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Daklak Stock
If you are still planning to invest in Daklak Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Daklak Pharmaceutical's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |